Posted on 5 月 18, 20205/18/20
Deciphera’s Qinlock Approved for Fourth-Line GIST Treatment by FDA
Posted on 5 月 13, 20205/13/20
Minnesota to Require Drugmakers to Justify Price Hikes
Posted on 5 月 11, 20205/11/20
FDA OK’s AZ & Merck’s Lynparza Plus Bevacizumab in HRD-Positive Ovarian Cancer
Posted on 4 月 28, 20204/28/20
ICER Analysis of Vertex’s 4 CFTR Modulators Hails Benefit of Trikafta but Suggests 73% Discount
Posted on 4 月 8, 20204/8/20
FDA Grants Priority Review to Merck’s Keytruda, Use Based on Biomarker Regardless of Tumor Type
Posted on 2 月 23, 20202/23/20
FDA Publishes Final Rule on New Regulatory Pathway Shift for Insulin, Other Biologics
Posted on 1 月 29, 20201/29/20